IDENTIFICATION OF SPECIFIC MUTATIONS IN HUMAN RAS GENE

被引:0
|
作者
Ahmed, Mohammed Qumani [1 ]
Hussain, Syed Nazar [1 ]
Al-Hazimi, Awdah Masoud [1 ]
Fazaludeen, Mohammad Feroze [1 ]
Elasbali, Abdelbaset Mohamed [1 ]
Ginawi, Ibrahim [1 ]
机构
[1] Univ Hail, Coll Med, Dept Pharmacol, MS Pharmacol, Hail, Saudi Arabia
关键词
Bioinformatics tools; Primer designing; H-Ras; K-Ras and N-Ras mutations;
D O I
10.13040/IJPSR.0975-8232.3(10).3893-14
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is a group of disease characterized by unregulated cell growth and spread of cells from site of origin to other sites in body. Two main genetic changes lead to cancer they are inactivation of tumour suppressor gene and activation of proto-oncogene. Ras gene is a proto-oncogene, when this gene activated it stimulates signalling pathway and that causes unregulated proliferation of cells. Ras family is a group of three precursors H-Ras, K-Ras and N-Ras. It was analyzed that more than 30% of cancers occurs due to Ras gene. But most of the Ras related cancers are occur due to mutations in H-Ras gene. In H-Ras gene codons 12, 13 and 61 are hotspots. Bioinformatics tools are help to find out the amino acid sequence from which got the gene sequence of H-Ras. Using the H-Ras gene sequence, six primer pairs were designed to amplify the DNA of patients with the potential mutations. Designed primers can be used for the diagnosis of H-Ras related cancers.
引用
收藏
页码:3893 / 3914
页数:22
相关论文
共 50 条
  • [21] Identification of two novel missense mutations in the human OB gene
    SM Echwald
    SB Rasmussen
    TIA Sørensen
    T Andersen
    A Tybjærg-Hansen
    JO Clausen
    L Hansen
    T Hansen
    O Pedersen
    International Journal of Obesity, 1997, 21 : 321 - 326
  • [22] SOMATIC DELETIONS AND MUTATIONS OF C-HA-RAS GENE IN HUMAN CERVICAL CANCERS
    RIOU, G
    BARROIS, M
    SHENG, ZM
    DUVILLARD, P
    LHOMME, C
    ONCOGENE, 1988, 3 (03) : 329 - 333
  • [23] CHROMOSOMAL DELETIONS AND K-RAS GENE-MUTATIONS IN HUMAN ENDOMETRIAL CARCINOMAS
    IMAMURA, T
    ARIMA, T
    KATO, H
    MIYAMOTO, S
    SASAZUKI, T
    WAKE, N
    INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (01) : 47 - 52
  • [24] Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations
    Waldmann, V
    Rabes, HM
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (04) : 207 - 213
  • [25] ABSENT RAS GENE-MUTATIONS IN HUMAN ADRENAL-CORTICAL NEOPLASMS AND PHEOCHROMOCYTOMAS
    MOUL, JW
    BISHOFF, JT
    THEUNE, SM
    CHANG, EH
    JOURNAL OF UROLOGY, 1993, 149 (06): : 1389 - 1394
  • [26] LOW PREVALENCE OF ACTIVATING K-RAS GENE-MUTATIONS IN HUMAN HEPATOCARCINOGENESIS
    CHALLEN, C
    MUTIMER, DJ
    CAVANAGH, D
    BASSENDINE, MF
    HEPATOLOGY, 1990, 12 (02) : 393 - 393
  • [27] TISSUE-SPECIFIC HYPOMETHYLATION OF THE HUMAN C-K-RAS GENE
    METTER, J
    CHO, C
    NUCLEIC ACIDS RESEARCH, 1989, 17 (17) : 7089 - 7099
  • [28] ras gene mutations and expression of ras signal transduction mediators in gastric adenocarcinomas
    Yoo, J
    Park, SY
    Robinson, RA
    Kang, SJ
    Ahn, WS
    Kang, CS
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2002, 126 (09) : 1096 - 1100
  • [29] Identification of gait mutations using specific assays and gene 2 scanning.
    McKinney, J
    Campbell, M
    Dobrowolski, S
    Zhao, W
    Saunders, C
    GENETICS IN MEDICINE, 2004, 6 (04) : 356 - 356
  • [30] MUTATIONS OF RAS GENES IN HUMAN TUMORS (REVIEW)
    KIARIS, H
    SPANDIDOS, DA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (03) : 413 - 421